EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Prognostic Biomarkers of Ovarian High-Grade Serous Carcinoma: A Preliminary Study Using Spatial Transcriptome Analysis and Multispectral Imaging

Haeyoun Kang iD, Je-Gun Joung, Hyun Park, Min Chul Choi iD, Doohyun Koh, Ju-Yeon Jeong, Jimin Lee, Sook-Young Kim, Daun Jung, Sohyun Hwang iD, Hee Jung An

Cells · 2025

DOI: 10.3390/cells14100681 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Haeyoun Kang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Republic of Korea. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Biomarkers, Tumor, Cystadenocarcinoma, Serous, Gene Expression Profiling. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Science and ICT, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer is a lethal malignancy, with most patients initially responding to chemotherapy but frequently experiencing recurrence. Previous studies primarily examined tumor characteristics using limited genetic markers or bulk RNA sequencing. Here, we used spatial transcriptomics via the GeoMx® platform, alongside multispectral immune cell immunofluorescence (IF), to identify biomarkers associated with disease progression following first-line treatment of high-grade serous carcinoma (HGSC). We identified several spatial biomarkers linked to non-recurrence, including elevated NKG7 expression in CD45+ immune cell regions (p = 0.0011) and higher TFPI2 and PIGR expression in tumor areas (p = 2.09 × 10−6), both associated with improved progression-free survival. Multispectral IF revealed significantly higher regulatory T cell (Treg) to CD8+ T cell ratios in the tumor nests and stroma of recurrent patients (p = 0.016, 0.048). Tregs were also found closer to cancer cells or macrophages than CD8+ T cells in recurrent tumors (p = 0.048), correlating with poor survival. Integrated analysis showed that immune cell density and immune pathway scores in the recurrent group positively correlated with cancer pathway scores, except for NF-κB. This comprehensive analysis revealed clues to interactions between different immune cells and identified biomarkers that may be useful for predicting recurrence of HGSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsBiomarkers, TumorCystadenocarcinoma, SerousGene Expression ProfilingTranscriptomeHumansFemalePrognosisMiddle AgedAgedNeoplasm Recurrence, LocalGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

biomarkerscancer recurrenceovarian cancerspatial transcriptomicstumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Republic of Korea.
  • Department of Biomedical Science, CHA University, Seongnam 13496, Republic of Korea.
  • CHA Future Medicine Research Institute, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Republic of Korea.
  • Department of Biomedical Informatics, CHA University, Seongnam 13496, Republic of Korea.
  • Department of Gynecological Oncology, Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Republic of Korea.
  • Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

ORCID-Profile: Haeyoun Kang, Min Chul Choi, Sohyun Hwang

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Science and ICT
  • Ministry of Education

Zitieren

APA

Kang, H., Joung, J. G., Park, H., Choi, M. C., Koh, D., Jeong, J. Y., Lee, J., Kim, S. Y., Jung, D., Hwang, S., & An, H. J. (2025). Identification of Prognostic Biomarkers of Ovarian High-Grade Serous Carcinoma: A Preliminary Study Using Spatial Transcriptome Analysis and Multispectral Imaging. Cells. https://doi.org/10.3390/cells14100681

Vancouver

Kang H, Joung JG, Park H, Choi MC, Koh D, Jeong JY, et al. Identification of Prognostic Biomarkers of Ovarian High-Grade Serous Carcinoma: A Preliminary Study Using Spatial Transcriptome Analysis and Multispectral Imaging. Cells. 2025. doi:10.3390/cells14100681

BibTeX
@article{Kang2025,
  author = {Kang, Haeyoun and Joung, Je-Gun and Park, Hyun and Choi, Min Chul and Koh, Doohyun and Jeong, Ju-Yeon and Lee, Jimin and Kim, Sook-Young and Jung, Daun and Hwang, Sohyun and An, Hee Jung},
  title = {Identification of Prognostic Biomarkers of Ovarian High-Grade Serous Carcinoma: A Preliminary Study Using Spatial Transcriptome Analysis and Multispectral Imaging},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14100681}
}
Kostenlos starten →